Lab Med Online.  2017 Jan;7(1):1-6. 10.3343/lmo.2017.7.1.1.

Guidelines for the Performance Evaluation of In-Vitro Diagnostic Test for the Detection of Norovirus Infection in Korea

• Kim J
• Kim HS
• Lee S
• Oh SH
• Woo KS
• Kim SY
• Min EK

• KMID: 2362999
• DOI: http://doi.org/10.3343/lmo.2017.7.1.1

Abstract

Norovirus is a leading cause of epidemic and sporadic acute gastroenteritis worldwide. Rapid and accurate detection of norovirus is essential for the prevention and control of norovirus outbreaks. The purpose of this study was to propose and develop a process for establishing appropriate standardized guidelines for the approval and evaluation of in vitro diagnostic medical devices (IVDD) for norovirus detection in Korea based on the related laws, regulations, and guidelines of USA, Europe, and Korea. We expect that this study could be used for diagnostic test standardization and the approval and evaluation of domestic norovirus diagnostic devices. We also expect the results will contribute to industrial expansion and public health promotion.

Keyword

Norovirus; In-Vitro Diagnostic Device; Evaluation; Guideline

MeSH Terms

Diagnostic Tests, Routine*
Disease Outbreaks
Europe
Gastroenteritis
Jurisprudence
Korea*
Norovirus*
Public Health
Reagent Kits, Diagnostic
Social Control, Formal
Reagent Kits, Diagnostic

Reference

1. Park DJ, Kim JS, Park JY, Kim HS, Song W, Kim HS, et al. [Epidemiological analysis of norovirus infection between March 2007 and February 2010]. Korean J Lab Med. 2010; 30:647–53.

2. Desselberger U, Goodfellow I. Noroviruses: a global cause of acute gastroenteritis. Lancet Infect Dis. 2014; 14:664–5.

3. Lee H, Park Y, Kim M, Jee Y, Cheon DS, Jeong HS, et al. Development of a latex agglutination test for norovirus detection. J Microbiol. 2010; 48:419–25.

4. Kim HS, Hyun J, Kim JS, Song W, Kang HJ, Lee KM. Evaluation of the SD Bioline Norovirus rapid immunochromatography test using fecal specimens from Korean gastroenteritis patients. J Virol Methods. 2012; 186:94–8.

5. Hyun J, Kim HS, Kim HS, Lee KM. Evaluation of a new real-time re-verse transcription polymerase chain reaction assay for detection of norovirus in fecal specimens. Diagn Microbiol Infect Dis. 2014; 78:40–4.

6. Vinje J. Advances in laboratory methods for detection and typing of norovirus. J Clin Microbiol. 2015; 53:373–81.

7. Medical Device Technique Law No. 13116 (2015. 4), Medical Device Technology Enforcement Decree No. 24480 (2015.7), Medical Device Technology Enforcement Rule No. 1181 (2015.7).

8. Regulations on medical device licensing, notifcation and examination Article 33 (Types and Requirements of Examination Documents of Medical Devices for In-vitro Diagnosis) (2015.2) Ministry of Food and Drug Safety.

9. Regulations on the Classifcation of Medical Device. Safety Notifcation No. 2015-18 (May 4, 2015), Ministry of Food and Drug Safety.

10. Clinical performance test management guideline of in vitro diagnostic medical device Article 24 (2015.7).

11. In vitro diagnostic medical devices Guidelines for approval and screening of rotavirus and adenovirus (2015.2) Ministry of Food and Drug Safety.

12. Guideline for screening gynecological virus (CMV) medical devices for in-vitro diagnostics during prenatal testing (2015.2) Ministry of Food and Drug Safety.

13. Rubella virus in prenatal test Guidelines for screening for medical devices for in vitro diagnostics (2015.2) Ministry of Food and Drug Safety.

14. Guidelines for Screening of Medical Devices for In Vitro Diagnosis of Herpes Simplex Virus (HSV) during Prenatal Examination (2015.2) Ministry of Food and Drug Safety.

15. U.S. Food and Drug Administration (FDA). Guidance for Industry and Food and Drug Administration Staff- Statistical guidance on reporting results from studies evaluating diagnostic tests. http://www.fda.gov/RegulatoryInformation/Guidances/ucm071148.htm. (Updated on March 13, 2007).

16. U.S. FDA. Guidance for Industry and Food and Drug Administration Staff-Class II Special Controls Guidance Document: Norovirus Serological Reagents. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Guidancedocuments/ucm295088.htm. (Updated on March 9, 2012).

17. U.S. FDA. Guidance for Industry and Food and Drug Administration Staff- Class II Special Controls Guideline: Gastrointestinal Microorganism Multiplex Nucleic Acid-Based Assays for Detection and Identifcation of Microorganisms and Toxin Genes from Human Stool Specimens. http://www.fda.gov/downloads/MedicalDevices/DeviceRegulation-andGuidance/GuidanceDocuments/UCM470559.pdf. (Updated on November 2, 2015).

18. U.S. FDA. 510(k) premarket notifcation. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm. (Updated on January 2016).

19. Clinical and Laboratory Standards Institute. Molecular Diagnostic Methods for Infectious Disease, 3rd Edition, MM03-Ed3, Wayne, PA: Clinical and Laboratory Standards Institute. 2015.

20. Clinical and Laboratory Standards Institute. Verifcation and validation of multiplex nucleic acid assays; approved guideline, MM17-A, Wayne, PA: Clinical and Laboratory Standards Institute. 2008.

21. European Community. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. http://ec.europa.eu/growth/single-market/european-standards/harmonised-standards/iv-diagnostic-medical-devices/index_en.htm. (Updated on January 2016).

22. European Commission. 2009/886/EC: Commission Decision of 27 November 2009 amending Decision 2002/364/EC on common technical specifcations for in vitro diagnostic medical devices (notifed under document C (2009). http://www.itczlin.cz/editor/fles/root_f/cz-MDD/DIRECTIVES/Corr_2009_886_EC.pdf. (Updated on January 2016).

23. Korean Society for Laboratory Medicine. Medical glossary for laboratory medicine. Academia. 2010.